跳至主要内容
临床试验/EUCTR2006-005025-31-DE
EUCTR2006-005025-31-DE进行中(未招募)不适用

Efficacy and Safety of St. John´s Wort/Valerian Extract (Sedariston Concentrate) versus Placebo in Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) - SED-ADHS

niversitätsmedizin der Johannes Gutenberg-Universität Mainz0 个研究点开始时间: 2008年6月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Written Informed Consent by parents and patients (separately for age groups 6 – 11 years and 12 – 17 years)
  • -Children and adolescents of both sexes in the age group between 6 and 17 years
  • -Confirmed diagnosis of ADHD by semi-structured clinical interview K-SADS verified (score ADHDRS-IV-Parent Version (18-Item-Scale): Investigator Administered and Scored =24)
  • -Acceptance and Capability to swallow capsules of size 1
  • -Sufficient knowledge of the German language
  • -Sexually mature and active adolescents with highly effective methods of birth control: contraception according to Pearl-Index<1; when use of oral contraceptives, additional methods of contraception (e.g. condomes) are necessary, i.e. double-barrier
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Known hypersensitivity against St. John´s wort or Valerian root or one of the excipients
  • -Known hypersensitivity of the skin when exposed to sunlight
  • -All serious internal diseases, and for this reason:
  • -Current intake of following medication: Ciclosporin, Tacrolimus, Indinavir and other protease inhibitors in the anti-HIV treatment, Irinotecan and other cytostatics, anticoagulants of the Cumarin-type, Digoxin, Amitriptylin, Nortriptylin, Midazolam, Theophyllin or other medication with photosensitive effects
  • -All severe psychiatric diseases except oppositional defiant disorders (according to items 21-28 SNAP-IV) and conduct disorders (according to items 41-45 SNAP-IV), and for this reason:
  • -Current intake of the following medication: antidepressants and other psychotropic medication
  • -Indication for hospitalization
  • -Suicidality (including suicidal thoughts): Score =3 in item 10 of MADRS
  • -Pregnancy, lactation
  • -Positive screening for metabolites of illegal drugs in urine
  • -Previous medication with stimulants and/or atomoxetine
  • -Psychotropic co-medication
  • -Placement in an institution on official or judicial ruling
  • -Lack of willingness to store and transmit pseudonym data according to German regulations
  • -Parallel participation in another clinical trial according to German Drug Law (AMG), or less than 4 weeks ago
  • -Patients requiring a primary medication with methylphenidate during the study period of 8 weeks

研究者

相似试验